Cerebrospinal fluid mitochondrial DNA: A novel DAMP in pediatric traumatic brain injury

Shock

Volumn 41, Issue 6, 2014, Pages 499-503

  Walko, Thomas D ^a   Bola, R Aaron ^b   Hong, John D ^c   Au, Alicia K ^d   Bell, Michael J ^d   Kochanek, Patrick M ^d   Clark, Robert S B ^d   Aneja, Rajesh K ^d  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c CARNEGIE MELLON UNIVERSITY   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

cerebrospinal fluid; Mitochondrial DNA; traumatic brain injury

Indexed keywords

BIOLOGICAL MARKER; MITOCHONDRIAL DNA; HIGH MOBILITY GROUP B1 PROTEIN;

ADOLESCENT; ARTICLE; CELL DEATH; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; HUMAN; INNATE IMMUNITY; INTENSIVE CARE UNIT; INTRACRANIAL PRESSURE MONITORING; LUMBAR PUNCTURE; MALE; MENINGOENCEPHALITIS; MOTOR VEHICLE; OUTCOME ASSESSMENT; SURVIVOR; TRAUMATIC BRAIN INJURY; BRAIN INJURY; INFANT; PRESCHOOL CHILD;

ADOLESCENT; BIOLOGICAL MARKERS; BRAIN INJURIES; CHILD; CHILD, PRESCHOOL; DNA, MITOCHONDRIAL; FEMALE; HMGB1 PROTEIN; HUMANS; INFANT; MALE;

EID: 84901616866     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000160     Document Type: Article

References (34)

1. Selassie AW, Zaloshnja E, Langlois JA, Miller T, Jones P, Steiner C: Incidence of long-term disability following traumatic brain injury hospitalization, United States, 2003. J Head Trauma Rehabil 23(2):123-131, 2008
2. Rutland-Brown W, Langlois JA, Thomas KE, Xi YL: Incidence of traumatic brain injury in the United States, 2003. J Head Trauma Rehabil 21(6): 544-548, 2006
3. Faul M, Xu L, Wald MM, VG C: Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths 2002-2006. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control, 2010
4. Hutchinson PJ, Oconnell MT, Rothwell NJ, Hopkins SJ, Nortje J, Carpenter KL, Timofeev I, Al-Rawi PG, Menon DK, Pickard JD: Inflammation in human brain injury: Intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1ra. J Neurotrauma 24(10):1545-1557, 2007
5. Fink KB, Andrews LJ, Butler WE, Ona VO, Li M, Bogdanov M, Endres M, Khan SQ, Namura S, Stieg PE, et al.: Reduction of post-traumatic brain injury and free radical production by inhibition of the caspase-1 cascade. Neuroscience 94(4):1213-1218, 1999
6. Bell MJ, Kochanek PM, Doughty LA, Carcillo JA, Adelson PD, Clark RS, Wisniewski SR, Whalen MJ, DeKosky ST: Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. J Neurotrauma 14(7):451-457, 1997
7. Wang H, Bloom O, Zhang M, Vishnubhakat JM, OmbrellinoM, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et al.: HMG-1 as a late mediator of endotoxin lethality in mice. Science 285(5425):248-251, 1999
8. Wang H, Yang H, Tracey KJ: Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med 255(3):320-331, 2004
9. Bianchi ME: DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 81(1):1-5, 2007
10. Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, Nagashima M, Lundh ER, Vijay S, Nitecki D: The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and coexpression of rage and amphoterin in the developing nervous system. J Biol Chem 270(43):25752-25761, 1995
11. Kim JY, Park JS, Strassheim D, Douglas I, Diaz Del Valle F, Asehnoune K, Mitra S, Kwak SH, Yamada S, Maruyama I, et al.: HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol 288(5):L958YL965, 2005
12. Lotze MT, Tracey KJ: High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev Immunol 5(4):331-342, 2005
13. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, Abraham E: Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279(9):7370-7377, 2004
14. West AP, Shadel GS, Ghosh S: Mitochondria in innate immune responses. Nat Rev Immunol 11(6):389-402, 2011
15. Zhang Q, Itagaki K, Hauser CJ: Mitochondrial DNA is released by shock and activates neutrophils via p38 map kinase. Shock 34(1):55-59, 2010
16. West AP, Koblansky AA, Ghosh S: Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol 22:409-437, 2006
17. Zhang Q, Raoof M, Chen Y, SumiY, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ: Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464(7285):104-107, 2010
18. Exo J, Kochanek PM, Adelson PD, Greene S, Clark RS, Bayir H, Wisniewski SR, Bell MJ: Intracranial pressure-monitoring systems in children with traumatic brain injury: Combining therapeutic and diagnostic tools. Pediatr Crit Care Med 12(5):560-565, 2011
19. Adelson PD, Bratton SL, Carney NA, Chesnut RM, du Coudray HE, Goldstein B, Kochanek PM, Miller HC, Partington MP, Selden NR, et al.: Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents. Chapter 19. The role of anti-seizure prophylaxis following severe pediatric traumatic brain injury. Pediatr Crit Care Med 4(Suppl 3):S72YS75, 2003
20. Satchell MA, Lai Y, Kochanek PM, Wisniewski SR, Fink EL, Siedberg NA, Berger RP, DeKosky ST, Adelson PD, Clark RS: Cytochrome c, a biomarker of apoptosis, is increased in cerebrospinal fluid from infants with inflicted brain injury from child abuse. J Cereb Blood Flow Metab 25(7):919-927, 2005
21. Simmons JD, Lee YL, Mulekar S, Kuck JL, Brevard SB, Gonzalez RP, Gillespie MN, Richards WO: Elevated levels of plasma mitochondrial DNA DAMPs are linked to clinical outcome in severely injured human subjects. Ann Surg 258(4):591-596, 2013
22. Chiu RW, Chan LY, Lam NY, Tsui NB, Ng EK, Rainer TH, Lo YM: Quantitative analysis of circulating mitochondrial DNA in plasma. Clin Chem 49(5): 719-726, 2003
23. Au AK, Aneja RK, Bell MJ, Bayir H, Feldman K, Adelson PD, Fink EL, Kochanek PM, Clark RS: Cerebrospinal fluid levels of high-mobility group box 1 and cytochrome C predict outcome after pediatric traumatic brain injury. J Neurotrauma 29(11):2013-2021, 2012
24. Matzinger P: The danger model: A renewed sense of self. Science 296(5566): 301-305, 2002
25. Garg AD, Nowis D, Golab J, Vandenabeele P, Krysko DV, Agostinis P: Immunogenic cell death, DAMPs and anticancer therapeutics: An emerging amalgamation. Biochim Biophys Acta 1805(1):53-71, 2010
26. Taanman JW: The mitochondrial genome: Structure, transcription, translation and replication. Biochimica et Biophysica Acta (BBA)-Bioenergetics 1410(2): 103-123, 1999
27. Andersson SG, Karlberg O, Canback B, Kurland CG: On the origin of mitochondria: A genomics perspective. Philos Trans R Soc Lond B Biol Sci 358(1429): 165-179, 2003
28. Podlesniy P, Figueiro-Silva J, Llado A, Antonell A, Sanchez-Valle R, Alcolea D, Lleo A, Molinuevo JL, Serra N, Trullas R: Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease. Ann Neurol 74(5):655-668, 2013
29. Zimmerman RA, Bilaniuk LT, Bruce D, Schut L, Uzzell B, Goldberg HI: Computed tomography of craniocerebral injury in the abused child. Radiology 130(3):687-690, 1979
30. Chan KH, Yue CP, Mann KS: The risk of intracranial complications in pediatric head injury. Results of multivariate analysis. Childs Nerv Syst 6(1): 27-29, 1990
31. Barlow K, Thompson E, Johnson D, Minns RA: The neurological outcome of non-accidental head injury. Pediatr Rehabil 7(3):195-203, 2004
32. Shore PM, Berger RP, Varma S, Janesko KL, Wisniewski SR, Clark RS, Adelson PD, Thomas NJ, Lai YC, Bayir H, et al.: Cerebrospinal fluid biomarkers versus glasgow coma scale and glasgow outcome scale in pediatric traumatic brain injury: The role of young age and inflicted injury. J Neurotrauma 24(1):75-86, 2007
33. Venereau E, Schiraldi M, Uguccioni M, Bianchi ME: HMGB1 and leukocyte migration during trauma and sterile inflammation. Mol Immunol 55(1): 76-82, 2013
34. Manganelli V, Signore M, Pacini I, Misasi R, Tellan G, Garofalo T, Lococo E, Chirletti P, Sorice M, Delogu G: Increased HMGB1 expression and release by mononuclear cells following surgical/anesthesia trauma. Crit Care 14(6): R197, 2010